Survival Outcomes of an Early Intervention Smoking Cessation Treatment After a Cancer Diagnosis
Top Cited Papers
Open Access
- 1 December 2024
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 10 (12) , 1689-1696
Abstract
Smoking by patients with cancer and cancer survivors causes adverse cancer treatment outcomes.1 The 2014 Surgeon General’s report on tobacco reviewed more than 400 studies between 1992 and 2012, concluding that smoking at or following a cancer diagnosis increases both all-cause and cancer-specific mortality, as well as risk for disease progression and tobacco-related second primary cancers. Across various cancer types, continuing to smoke increased the risk of overall mortality by a median rate of 50% and cancer-related mortality by a median rate of 61%. The adverse effects of smoking on cancer treatment outcomes and costs are observed across cancer disease types.2 The 2020 Surgeon General’s report and recent meta-analyses among patients with lung or head and neck cancer support improved survival with quitting smoking among these patients.3-5 However, a significant limitation noted by these reviews was the lack of clear, consistent smoking data and prospective longitudinal outcomes. Importantly, none of these earlier studies analyzed the association of time between diagnosis and entry into a smoking cessation treatment program with survival.Keywords
This publication has 32 references indexed in Scilit:
- Quitting smoking improves two-year survival after a diagnosis of non-small cell lung cancerLung Cancer, 2023
- Treatment of Tobacco SmokingJAMA, 2022
- Quitting Smoking At or Around Diagnosis Improves the Overall Survival of Lung Cancer Patients: A Systematic Review and Meta-AnalysisJournal of Thoracic Oncology, 2022
- Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With CancerJAMA, 2020
- Association of a Comprehensive Smoking Cessation Program With Smoking Abstinence Among Patients With CancerJAMA Network Open, 2019
- Attributable Failure of First-line Cancer Treatment and Incremental Costs Associated With Smoking by Patients With CancerJAMA Network Open, 2019
- Smoking at diagnosis and survival in cancer patientsInternational Journal of Cancer, 2012
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- ‘Intention-to-treat’ meets ‘missing data’: implications of alternate strategies for analyzing clinical trials dataDrug and Alcohol Dependence, 2002
- Measuring nicotine dependence: A review of the Fagerstrom Tolerance QuestionnaireJournal of Behavioral Medicine, 1989